Intellia Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.About NTLA
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.
NTLA Key Statistics
NTLA News
20:32 EDT Cathie Wood’s ARK Investment buys 99K shares of Intellia Therapeutics (NTLA) today Published first on TheFly – the ultimate source for real-time, mar...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio adjustments on Monday, September 29, according to daily fund disclosures. The ace h...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Friday, September 26, according to daily fund disclosures. T...
Analyst ratings
77%
of 26 ratingsMore NTLA News
Analyst Debanjana Chatterjee of JonesTrading maintained a Buy rating on Intellia Therapeutics, retaining the price target of $25.00. Elevate Your Investing Stra...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Intellia Therapeutics Inc. (NASDAQ: NTLA) on Thursday released longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran...
Intellia Therapeutics (NTLA) announced longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran for the treatment of he...